Menu
Back to Journals » Lung Cancer: Targets and Therapy » Volume 14
Commentary
CheckMate-722: The Rise and Fall of Nivolumab with Chemotherapy in TKI-Refractory EGFR-Mutant NSCLC
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,958 | Dovepress* | 3,561+ | 104 | 3,665 | |
| PubMed Central* | 2,397 | 554 | 2,951 | ||
| Totals | 5,958 | 658 | 6,616 | ||
| *Since 25 April 2023 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 5 | 0 | 0 | 1 | 1 | 3 |
View citations on PubMed Central and Google Scholar